Summary
Intravenous application of 100 µg synthetic ovine corticotropin releasing factor (CRF) led to stimulation of ACTH-secretion in nine normal controls, with a maximum 30 min after CRF. Cortisol, corticosterone, cortisone and 11-deoxycortisol increased with a maximum at 60 min after CRF, whereas no rise was seen in aldosterone, 11-deoxycorticosterone, 17-α-hydroxyprogesterone, progesterone, DHEA-S and testosterone. The specificity of CRF-stimulation was also shown by unchanged TSH, LH, FSH, hGH, prolactin and thyroid hormone levels, als well as unchanged insulin and gastrin levels. No serious side-effects were observed during the test period and afterwards.
CRF-tests were performed in ten patients with disturbances of the hypothalamo pituitary adrenal axis (HPAA). Preliminary findings show hyperresponsiveness of ACTH in all situations of ACTH-hypersecretion (two patients with Cushing's disease, one patient with Nelson's syndrome, and one with Addison's disease). In contrast, one patient with successful microadenomectomy showed no response of ACTH to CRF, whereas in another patient with a macroadenoma ACTH and cortisol-levels still increased postoperatively. Divergent patterns in ACTH-responsiveness to CRF were seen in four patients with secondary adrenal insufficiency, allowing the localization of the defect. These data point to the possible importance of the “CRF-test” as a differential diagnostic tool and prognostic factor in diseases of the HPAA.
Similar content being viewed by others
References
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79
Burgus R, Dunn Th F, Desiderio D, Ward DN, Vale W, Guillemin R (1970) Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature 226:321–325
Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R (1972) Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc Nat Acad Sci USA 69:278–282
Fisher LA, Rivier J, Rivier C, Spiess J, Vale W, Brown MR (1982) Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heartrate in rats. Endocrinology 110:2222–2224
Grossman A, Nieuwenhuysen Krusemann AG, Perry L, Tomlin S, Schally AV, Coy DH, Rees LH, Comaru-Schally AM, Besser GM (1982) New hypothalamic hormone, corticotropin-releasing factor specifically stimulates the release of adrenocorticotropic hormone and cortisol in man. Lancet 1:921–922
Guillemin R, Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: Study with combined tissue cultures. Endocrinology 57:599–607
Harris GW (1948) Neural control of the pituitary gland. Physiol Rev 28:139–173
Leyendecker G, Wildt L, Hansmann M (1980) Pregnancies following intermittent (pulsatile) administration of Gn-RH by means of a portable pump (“Zyklomat”) — a new approach to the treatment of infertility in hypothalamic amenorrhea. J Endocrinol Metab 51:1214–1216
Linton EA, Gillies GE, Lowry PJ (1982) Synergism between vasopressin and the new 41 residue corticotrophic releasing factor. Abstracts of the 64th annual meeting of the Endocrine Society, SF, Ca (Abstract 16)
Müller OA, Fink R, Baur X, Ehbauer M, Madler M, Scriba PC (1978) ACTH im Plasma: Extraktion und Bestimmung. GIT Labormed 2:117–124
Müller OA (1980) ACTH im Plasma: Bestimmungsmethoden und klinische Bedeutung. Thieme, Stuttgart
Müller OA, Fahlbusch R (1982) Zentrales Cushing-Syndrom: Therapie und Verlauf. Verh Dtsch Ges Inn Med 88:1114–1118
Odell WD, Swerdloff RS (1978) Abnormalities of gonadal function in men. Clin Endocrinol (Oxf) 8:149–180
Pickardt CR, Horn K, Scriba PC (1972) Moderne Aspekte der Schilddrüsenfunktionsdiagnostik Serum-T3-Spiegel und TRH-Stimulationstest mit radioimmunologischer TSH-Bestimmung. Internist (Berl) 13:133–140
Rivier C, Brownstein M, Spiess J, River J, Vale W (1982) In vitro corticotropin-releasing-factor-induced secretion of adrenocorticotropin, beta-endophine and corticosterone. Endocrinology 110:272–278
Saffran M, Schally AV (1955) The release of corticotrophin by anterior pituitary in vivo. Can J Biochem Physiol 33:408–415
Schally AV, Redding TW, Bowers CY, Barrett HJF (1969) Isolation and properties of porcine thyreotropine-releasing hormone. J Biol Chem 244:4077–4088
Schally AV, Arimura A, Baba Y, Nair RMG, Matsuo H, Redding TW, Debeljuk L, White WF (1971) Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 43:393–399
Sippell WG, Bidlingmeier F, Becker H, Brunig T, Dörr H, Hehn H, Goldes W, Hollmann G, Knorr D (1978) Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone. J Steroid Biochem 9:63–74
Stalla GK, Giesemann G, Müller OA, Wood WG, Scriba PC (1981) The development of a direct homologous radioimmunoassay for serum cortisol. J Clin Chem Biochem 19:427–434
Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphine. Science 213:1394–1397
White MC, Adams EF, Loizou M, Mashiter K, Fahlbusch R (1982) Corticotropin releasing factor stimulates ACTH-release from human pituitary corticotropic tumour cells in culture. Lancet 2:1251–1252
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft (Sonderforschungsbereich 51)
Rights and permissions
About this article
Cite this article
Müller, O.A., Dörr, H.G., Hagen, B. et al. Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis. Klin Wochenschr 60, 1485–1491 (1982). https://doi.org/10.1007/BF01716099
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716099